-

Piper Sandler Mourns the Loss of Board Member Sherry Smith

MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR) is deeply saddened to announce the unexpected passing of Sherry Smith, a valued and respected member of our board of directors.

Sherry served as a director of Piper Sandler since 2016 and was a dedicated and insightful leader, who brought a wealth of experience, financial expertise, and unwavering integrity to the firm. Her contributions over the years were incredibly helpful during a period of significant growth. She served as chairperson of the Audit Committee.

“Sherry was an outstanding director and an even better person,” said Chad Abraham, chairman and chief executive officer of Piper Sandler. “She provided steady leadership, sound judgment, and a deep sense of purpose in every board discussion. Her loss is profoundly felt by all of us, and we will miss her tremendously.”

“Sherry brought humility, clarity, and insight to every meeting that she was involved in. She had a unique ability to listen deeply, ask the right questions, and help the board and management see issues more clearly. We are grateful for the time we got to spend with her and for her service and dedication to the firm. Sherry will be missed dearly,” said Tom Schreier, lead independent director of Piper Sandler.

Prior to her board service, Sherry held senior leadership roles at SuperValu Inc., including executive vice president and chief financial officer. Her outstanding career in finance and corporate leadership made her a trusted voice in the industry and a respected mentor to countless people. In addition to serving on the Piper Sandler board, she was serving as the lead director for Deere & Company.

Piper Sandler extends its heartfelt condolences to Sherry’s family, friends, and all who had the privilege of knowing or working with her.

ABOUT PIPER SANDLER
Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in the U.K. through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; in the EU through Aviditi Capital Advisors Europe GmbH, a tied agent of AHP Capital Management GmbH, authorized and regulated by BaFin; and in Hong Kong through Piper Sandler Hong Kong Ltd., authorized and regulated by the Securities and Futures Commission. Alternative asset management and fixed income advisory services are offered through separately registered advisory affiliates.

Follow Piper Sandler: LinkedIn | Facebook | X

©2025. Since 1895. Piper Sandler Companies. 800 Nicollet Mall, Minneapolis, Minnesota 55402-7036

Contacts

Nick Lawler
Tel: 212 891-8954
nick.lawler@psc.com

Piper Sandler Companies

NYSE:PIPR

Release Versions

Contacts

Nick Lawler
Tel: 212 891-8954
nick.lawler@psc.com

More News From Piper Sandler Companies

Piper Sandler Strengthens Fixed Income Platform with the Addition of Distressed Debt and Special Asset Group

NEW YORK--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the additions of John Mori and Eric Friel as managing directors to lead a new group that will focus on distressed debt and special assets. Mori will be based in Greenwich and Friel will be in New York, both reporting to Michael Piper, head of fixed income at Piper Sandler. The distressed debt and special asset group will source and trade specialized credit products, including distr...

Piper Sandler Companies Reports First Quarter 2026 Results; Increases Quarterly Dividend to $0.20 Per Share

MINNEAPOLIS--(BUSINESS WIRE)--The complete earnings release can be found on the firm's website at pipersandler.com/earnings...

Piper Sandler Strengthens Healthcare Investment Banking Team with the Addition of Patrick McCormack

MINNEAPOLIS & SAN FRANCISCO--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Patrick McCormack, M.D. as a managing director in the healthcare investment banking group. McCormack will be based in San Francisco and focused on advising biopharma companies on mergers and acquisitions and capital-raising transactions. “We are excited to welcome Patrick to the healthcare investment banking team. His deep expertise advising bioph...
Back to Newsroom